With Crispr, a Possible Quick Test for the Coronavirus
A pioneer of the gene-editing technology has devised a diagnostic test for the infection that could be as simple as a pregnancy test.
SOSV's HAX is the most active early stage investor in hard tech startups, empowering founders building with robotics, internet of things, digital health, consumer products and industrial technologies. The HAX Program combines hands-on co-development with our experienced product development team, multi-stage venture capital investment, and collaboration with our global founder community building hard tech startups. Since 2012, HAX has invested in over 250 startups meshing hardware and software across its locations in San Francisco, Shenzhen and Tokyo.